日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction

CSL112(载脂蛋白AI[人])预防心肌梗死患者发生重大不良心血管事件的生物学基础和拟议作用机制

Korjian, Serge; Kazmi, Syed Hassan A; Chi, Gerald; Kalayci, Arzu; Lee, Jane J; Talib, Usama; Wright, Samuel D; Duffy, Danielle; Kingwell, Bronwyn A; Mehran, Roxana; Ridker, Paul M; Gibson, C Michael

ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future

急性冠脉综合征后ApoA-I输注疗法:过去、现在和未来

Kalayci, Arzu; Gibson, C Michael; Ridker, Paul M; Wright, Samuel D; Kingwell, Bronwyn A; Korjian, Serge; Chi, Gerald; Lee, Jane J; Tricoci, Pierluigi; Kazmi, S Hassan; Fitzgerald, Clara; Shaunik, Alka; Berman, Gail; Duffy, Danielle; Libby, Peter

Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity

中度肾功能损害不影响 CSL112(载脂蛋白 AI [人])增强胆固醇外流能力的能力。

Gille, Andreas; Duffy, Danielle; Tortorici, Michael A; Wright, Samuel D; Deckelbaum, Lawrence I; D'Andrea, Denise M

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function

CSL112(载脂蛋白AI[人])在中度肾功能损害和肾功能正常成人中的药代动力学和安全性

Tortorici, Michael A; Duffy, Danielle; Evans, Rebecca; Feaster, John; Gille, Andreas; Mant, Timothy G K; Wright, Samuel D; D'Andrea, Denise

CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients

CSL112(载脂蛋白AI[人])在健康个体和病情稳定的动脉粥样硬化患者中均能增强胆固醇外流。

Gille, Andreas; D'Andrea, Denise; Tortorici, Michael A; Hartel, Gunter; Wright, Samuel D

Circulating HDL levels control hypothalamic astrogliosis via apoA-I

循环中的高密度脂蛋白水平通过载脂蛋白A-I控制下丘脑星形胶质细胞增生。

Götz, Anna; Lehti, Maarit; Donelan, Elizabeth; Striese, Cynthia; Cucuruz, Sebastian; Sachs, Stephan; Yi, Chun-Xia; Woods, Stephen C; Wright, Samuel D; Müller, Timo D; Tschöp, Matthias H; Gao, Yuanqing; Hofmann, Susanna M

Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study

评估 CSL112(载脂蛋白 AI [人])在动脉粥样硬化患者中的潜在抗血小板作用:一项 2a 期研究的结果

Gurbel, Paul A; Tantry, Udaya S; D'Andrea, Denise; Chung, Thomas; Alexander, John H; Bliden, Kevin P; Wright, Samuel D; Tricoci, Pierluigi

A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease

清道夫受体的共识性最终分类及其在健康和疾病中的作用

PrabhuDas, Mercy R; Baldwin, Cynthia L; Bollyky, Paul L; Bowdish, Dawn M E; Drickamer, Kurt; Febbraio, Maria; Herz, Joachim; Kobzik, Lester; Krieger, Monty; Loike, John; McVicker, Benita; Means, Terry K; Moestrup, Soren K; Post, Steven R; Sawamura, Tatsuya; Silverstein, Samuel; Speth, Robert C; Telfer, Janice C; Thiele, Geoffrey M; Wang, Xiang-Yang; Wright, Samuel D; El Khoury, Joseph

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.

重组 HDL、CSL112 对 HDL 进行重塑后产生的小 HDL 物种增强了 HDL 的功能:对胆固醇外流、抗炎和抗氧化活性的影响

Didichenko Svetlana A, Navdaev Alexei V, Cukier Alexandre M O, Gille Andreas, Schuetz Patrick, Spycher Martin O, Thérond Patrice, Chapman M John, Kontush Anatol, Wright Samuel D

Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

在动脉粥样硬化患者中输注重组高密度脂蛋白CSL112:一项2a期随机临床试验的安全性和药代动力学结果

Tricoci, Pierluigi; D'Andrea, Denise M; Gurbel, Paul A; Yao, Zhenling; Cuchel, Marina; Winston, Brion; Schott, Robert; Weiss, Robert; Blazing, Michael A; Cannon, Louis; Bailey, Alison; Angiolillo, Dominick J; Gille, Andreas; Shear, Charles L; Wright, Samuel D; Alexander, John H